Rate the Article: Intravenous Immunoglobulin as a Therapeutic Option in Severe COVID-19 Patient: Case Report, IJSR, Call for Papers, Online Journal
International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064

Downloads: 57 | Views: 366 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Case Studies | Medical Science | Indonesia | Volume 10 Issue 3, March 2021 | Rating: 6.6 / 10


Intravenous Immunoglobulin as a Therapeutic Option in Severe COVID-19 Patient: Case Report

Yulia Karolina Kurniawati, Ongky Aristian, Anak Agung Gde Upeksha


Abstract: Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent for the ongoing pandemic of coronavirus disease 2019 (COVID-19). Until now, no definite effective treatment has been identified. Case Report: This article reports a 41 year old male, diagnosed with Confirmed Pneumonia COVID-19 with hypertension, transaminitis and obesity. The patient received high-dose intravenous immunoglobulin (IVIg) therapy. Conclusion: Patient was treated by intravenous immunoglobulin (IVIg) showed satisfactory recovery. Based on observations, IVIg should be considered in deteriorating patients infected with COVID-19. However further investigations are needed to explain this further.


Keywords: COVID-19, IVIg


Edition: Volume 10 Issue 3, March 2021,


Pages: 308 - 311



Rate this Article


Select Rating (Lowest: 1, Highest: 10)

5

Your Comments (Only high quality comments will be accepted.)

Characters: 0

Your Full Name:


Your Valid Email Address:


Verification Code will appear in 2 Seconds ... Wait

Top